US Stock MarketDetailed Quotes
JANX Janux Therapeutics
- 62.430
- +4.240+7.29%
Close May 2 16:00 ET
3.24BMarket Cap-47295P/E (TTM)
64.790High56.410Low1.12MVolume59.940Open58.190Pre Close67.80MTurnover5.95%Turnover RatioLossP/E (Static)51.85MShares64.79052wk High9.40P/B1.17BFloat Cap5.65052wk Low--Dividend TTM18.81MShs Float64.790Historical High--Div YieldTTM14.40%Amplitude5.650Historical Low60.641Avg Price1Lot Size
Janux Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -17.83%-50.58M | 16.89%-9.9M | 12.71%-11.71M | -147.88%-15.05M | -20.73%-13.91M | -152.84%-42.92M | -13.66%-11.91M | -129.14%-13.41M | 2.11%-6.07M | -307.12%-11.52M |
| Net income from continuing operations | 7.56%-58.29M | 26.81%-11.76M | 30.71%-11.57M | -3.67%-17.51M | -30.19%-17.46M | -93.01%-63.06M | -19.75%-16.07M | -55.08%-16.7M | -172.12%-16.89M | -487.13%-13.41M |
| Depreciation and amortization | 132.46%1.96M | 31.76%531K | 100.80%500K | 336.11%471K | 459.26%453K | 644.25%841K | 529.69%403K | 822.22%249K | 730.77%108K | 800.00%81K |
| Change In working capital | -253.27%-6.55M | -231.10%-1.1M | -287.55%-3.08M | -126.36%-1.68M | 67.09%-700K | -51.64%4.28M | 5,673.33%836K | -133.15%-795K | 606.53%6.36M | -127.57%-2.13M |
| -Change in receivables | ---- | ---- | ---- | ---- | ---750K | ---- | ---- | ---- | ---- | --0 |
| -Change in prepaid assets | 106.23%210K | 433.33%270K | 140.74%530K | -281.43%-2.24M | 217.79%1.65M | -86.65%-3.37M | -400.00%-81K | -2,925.58%-1.3M | 66.95%-587K | -10,669.23%-1.4M |
| -Change in payables and accrued expense | -110.38%-401K | -38.68%753K | -178.07%-1.76M | 3,537.84%1.27M | -259.57%-667K | -25.26%3.86M | -14.66%1.23M | -24.72%2.25M | -105.89%-37K | 290.65%418K |
| -Change in other current assets | 11.89%-1.12M | 37.70%-195K | 110.42%119K | -732.31%-822K | -501.82%-221K | -223.98%-1.27M | -24.21%-313K | -715.71%-1.14M | --130K | --55K |
| -Change in other working capital | -203.78%-5.24M | -286.35%-1.92M | -1,777.14%-1.97M | -109.31%-638K | 40.75%-711K | 337.45%5.05M | 59.48%-498K | 86.66%-105K | 6,448.15%6.86M | -29,900.00%-1.2M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -17.83%-50.58M | 16.89%-9.9M | 12.71%-11.71M | -147.88%-15.05M | -20.73%-13.91M | -152.84%-42.92M | -13.66%-11.91M | -129.14%-13.41M | 2.11%-6.07M | -307.12%-11.52M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -170.70%-41.19M | 793.45%11.12M | -410.94%-61.45M | 97.74%17.87M | -128.13%-8.74M | 117.09%58.27M | -121.89%-1.6M | 109.62%19.76M | 106.34%9.04M | 20,405.88%31.07M |
| Net PPE purchase and sale | 71.30%-1.85M | 74.95%-515K | 81.35%-470K | 35.41%-580K | 70.65%-285K | -334.89%-6.45M | -75.28%-2.06M | -3,172.73%-2.52M | -1,036.71%-898K | -534.64%-971K |
| Net investment purchase and sale | -160.80%-39.34M | 2,474.78%11.64M | -373.67%-60.98M | 85.71%18.45M | -126.39%-8.46M | 119.06%64.71M | -94.68%452K | 110.85%22.28M | 106.97%9.94M | --32.04M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -170.70%-41.19M | 793.45%11.12M | -410.94%-61.45M | 97.74%17.87M | -128.13%-8.74M | 117.09%58.27M | -121.89%-1.6M | 109.62%19.76M | 106.34%9.04M | 20,405.88%31.07M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 11,809.60%59.55M | 335.08%831K | 56.61M | 71.43%528K | 157,900.00%1.58M | -99.87%500K | 16.46%191K | 0 | -99.91%308K | -100.00%1K |
| Net common stock issuance | --56.53M | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | 503.60%3.02M | 335.08%831K | --79K | 71.43%528K | 157,900.00%1.58M | -72.38%500K | 16.46%191K | --0 | --308K | -99.94%1K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 11,809.60%59.55M | 335.08%831K | --56.61M | 71.43%528K | 157,900.00%1.58M | -99.87%500K | 16.46%191K | --0 | -99.91%308K | -100.00%1K |
| Net cash flow | ||||||||||
| Beginning cash position | 43.53%52.24M | -72.60%17.97M | -41.71%34.52M | -44.28%31.17M | 43.53%52.24M | 365.86%36.4M | 66.46%65.57M | -76.47%59.22M | -20.95%55.95M | 365.86%36.4M |
| Current changes in cash | -303.36%-32.22M | 115.41%2.05M | -360.69%-16.55M | 2.26%3.35M | -207.80%-21.07M | -44.57%15.84M | -345.54%-13.33M | 102.99%6.35M | -98.19%3.27M | -68.95%19.55M |
| End cash Position | -61.68%20.02M | -61.68%20.02M | -72.60%17.97M | -41.71%34.52M | -44.28%31.17M | 43.53%52.24M | 43.53%52.24M | 66.46%65.57M | -76.47%59.22M | -20.95%55.95M |
| Free cash flow | -6.19%-52.43M | 25.43%-10.42M | 23.57%-12.18M | -124.27%-15.63M | -13.63%-14.2M | -167.46%-49.37M | -19.86%-13.97M | -168.66%-15.93M | -10.95%-6.97M | -330.92%-12.49M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg